Gordon Lavigne, MEd, CEO of the Schizophrenia & Psychosis Action Alliance, talk about the joint FDA committee's vote on clozapine REMS.
Gordon Lavigne, MEd
Advertisement
Mr Lavigne is the chief executive officer of the Schizophrenia & Psychosis Action Alliance.
Articles by Gordon Lavigne, MEd
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Trial of ChatGPT: What Psychiatrists Need to Know About AI, Suicide, and the Law
2
Preliminary Report on Dangers of AI Chatbots
3
Closing the Gap in Schizophrenia Care: Insights From the INTEGRATE Guidelines
4
6 Helpful Pearls From the International Guidelines for Algorithmic Treatment of Schizophrenia
5
